MA12.04 FLAURA2: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemotherapy in Patients with EGFR-mutated Advanced NSCLC
Natalia Valdiviezo(Instituto Nacional de Enfermedades Neoplásicas), J.E. Gray(Moffitt Cancer Center), Pasi A. Jänne(Dana-Farber Cancer Institute), K. Kobayashi(Saitama International Medical Center), J.C.-H. Yang(National Taiwan University Hospital), Ying Cheng(Jilin Province Tumor Hospital), Chee Khoon Lee(St George Hospital), S. Sugawara(Sendai Kousei Hospital), Yu Yao(Harbin Medical University), Tae Min Kim(Seoul National University Hospital), S. Taggart(AstraZeneca (France)), Muna Albayaty(AstraZeneca (Poland)), D. Ghiorghui(AstraZeneca (Singapore)), D. Planchard(Université Paris-Saclay)
Cited by 9Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis